SANOFI DIAGNOSTICS PASTEUR – Trademark Portfolio

Entity Type: 03

SANOFI DIAGNOSTICS PASTEUR holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. The owner is based in F-92430 MARNES-LA-COQUETTE.

3, BOULEVARD RAYMOND POINCARE

F-92430 MARNES-LA-COQUETTE , FR

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SANOFI DIAGNOSTICS PASTEUR's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (8 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SANOFI DIAGNOSTICS PASTEUR have?

SANOFI DIAGNOSTICS PASTEUR has 11 U.S. trademarks filed with the USPTO.

What trademark classes does SANOFI DIAGNOSTICS PASTEUR file in?

SANOFI DIAGNOSTICS PASTEUR files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is SANOFI DIAGNOSTICS PASTEUR's trademark registration success rate?

SANOFI DIAGNOSTICS PASTEUR has a 0% trademark registration rate, with 0 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.